Chymase inhibition attenuates tetrachloride‐induced liver fibrosis in hamsters
Authors:
- 23 July 2010
- journal article
- research article
- Published by Wiley in Hepatology Research
- Vol. 40 (8) , 832-840
Abstract
Aim: Chymase converts angiotensin I to angiotensin II, which may promote the development of liver fibrosis. In this study, whether a chymase inhibitor TY‐51469 attenuated tetrachloride (CCl4)‐induced liver fibrosis was examined. Methods: Liver fibrosis was induced by the s.c. injection of 1 mL/kg of CCl4 twice weekly for 8 weeks, and each hamster was given TY‐51469 (1 mg/kg per day) or placebo. Untreated hamsters were used as a control group. Results: Significant increases of serum alanine aminotransferase, total bilirubin and hyaluronic acid levels were observed in the placebo‐treated group compared with the control group, but these levels were significantly attenuated in the TY‐51469‐treated group. Liver chymase activity was significantly higher in the placebo‐treated group than in the control group, whereas the activity in the TY51469‐treated group was not. Total angiotensin II‐forming activity in the liver was also significantly higher in the placebo‐treatedgroup than in the control group or the TY‐51469‐treated group. The ratio of the fibrotic area to the total area in the liver was significantly higher in the placebo‐treated group than in the control group, but the ratio was significantly lower in the TY‐51469‐treated group than in the placebo‐treated group. A significant decrease in the number of α‐smooth muscle actin (SMA)‐positive cells was seen in the TY‐51469‐treated group compared to the placebo‐treated group. Conclusion: Significant correlations between the number of chymase‐positive cells and the degree of fibrosis and between the numbers of chymase‐positive cells and α‐SMA‐positive cells were observed. Thus, chymase inhibition may be a useful strategy for preventing liver fibrosis.Keywords
This publication has 33 references indexed in Scilit:
- Chymase inhibitor prevents the nonalcoholic steatohepatitis in hamsters fed a methionine‐ and choline‐deficient dietHepatology Research, 2010
- Expression of angiotensin-converting enzyme 2 in CCL4-induced rat liver fibrosisInternational Journal of Molecular Medicine, 2009
- Chymase Inhibition Reduces the Progression to Heart Failure After Autoimmune Myocarditis in RatsExperimental Biology and Medicine, 2007
- Expression of angiotensin II type 1 receptor in human cirrhotic livers: Its relation to fibrosis and portal hypertensionHepatology Research, 2005
- Combined effect of an ACE inhibitor, perindopril, and interferon on liver fibrosis markers in patients with chronic hepatitis CJournal of Gastroenterology, 2005
- Angiotensin II generation by mast cell α- and β-chymasesBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 2000
- Purification and characterization of angiotensin II-generating chymase from hamster cheek pouchLife Sciences, 1996
- Intrahepatic mast cells in chronic liver diseasesHepatology, 1995
- Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells.Journal of Clinical Investigation, 1994
- Conversion of a high molecular weight latent β-TGF from chicken embryo fibroblasts into a low molecular weight active β-TGF under acidic conditionsBiochemical and Biophysical Research Communications, 1985